Literature DB >> 34089410

Challenge of prostate MRI segmentation on T2-weighted images: inter-observer variability and impact of prostate morphology.

Sarah Montagne1,2,3, Dimitri Hamzaoui4, Alexandre Allera5, Malek Ezziane5, Anna Luzurier5, Raphaelle Quint5, Mehdi Kalai5, Nicholas Ayache4, Hervé Delingette4, Raphaële Renard-Penna5,6,7.   

Abstract

BACKGROUND: Accurate prostate zonal segmentation on magnetic resonance images (MRI) is a critical prerequisite for automated prostate cancer detection. We aimed to assess the variability of manual prostate zonal segmentation by radiologists on T2-weighted (T2W) images, and to study factors that may influence it.
METHODS: Seven radiologists of varying levels of experience segmented the whole prostate gland (WG) and the transition zone (TZ) on 40 axial T2W prostate MRI images (3D T2W images for all patients, and both 3D and 2D images for a subgroup of 12 patients). Segmentation variabilities were evaluated based on: anatomical and morphological variation of the prostate (volume, retro-urethral lobe, intensity contrast between zones, presence of a PI-RADS ≥ 3 lesion), variation in image acquisition (3D vs 2D T2W images), and reader's experience. Several metrics including Dice Score (DSC) and Hausdorff Distance were used to evaluate differences, with both a pairwise and a consensus (STAPLE reference) comparison.
RESULTS: DSC was 0.92 (± 0.02) and 0.94 (± 0.03) for WG, 0.88 (± 0.05) and 0.91 (± 0.05) for TZ respectively with pairwise comparison and consensus reference. Variability was significantly (p < 0.05) lower for the mid-gland (DSC 0.95 (± 0.02)), higher for the apex (0.90 (± 0.06)) and the base (0.87 (± 0.06)), and higher for smaller prostates (p < 0.001) and when contrast between zones was low (p < 0.05). Impact of the other studied factors was non-significant.
CONCLUSIONS: Variability is higher in the extreme parts of the gland, is influenced by changes in prostate morphology (volume, zone intensity ratio), and is relatively unaffected by the radiologist's level of expertise.

Entities:  

Keywords:  Atlas; MRI; Prostate; Segmentation; Zones

Year:  2021        PMID: 34089410     DOI: 10.1186/s13244-021-01010-9

Source DB:  PubMed          Journal:  Insights Imaging        ISSN: 1869-4101


  20 in total

1.  A magnetic resonance spectroscopy driven initialization scheme for active shape model based prostate segmentation.

Authors:  Robert Toth; Pallavi Tiwari; Mark Rosen; Galen Reed; John Kurhanewicz; Arjun Kalyanpur; Sona Pungavkar; Anant Madabhushi
Journal:  Med Image Anal       Date:  2010-10-28       Impact factor: 8.545

2.  Combining a deformable model and a probabilistic framework for an automatic 3D segmentation of prostate on MRI.

Authors:  Nasr Makni; P Puech; R Lopes; A S Dewalle; O Colot; N Betrouni
Journal:  Int J Comput Assist Radiol Surg       Date:  2008-12-03       Impact factor: 2.924

3.  The use of atlas registration and graph cuts for prostate segmentation in magnetic resonance images.

Authors:  Anne Sofie Korsager; Valerio Fortunati; Fedde van der Lijn; Jesper Carl; Wiro Niessen; Lasse Riis Østergaard; Theo van Walsum
Journal:  Med Phys       Date:  2015-04       Impact factor: 4.071

Review 4.  [CCAFU french national guidelines 2016-2018 on prostate cancer].

Authors:  F Rozet; C Hennequin; J-B Beauval; P Beuzeboc; L Cormier; G Fromont; P Mongiat-Artus; A Ouzzane; G Ploussard; D Azria; I Brenot-Rossi; G Cancel-Tassin; O Cussenot; T Lebret; X Rebillard; M Soulié; R Renard-Penna; A Méjean
Journal:  Prog Urol       Date:  2016-11       Impact factor: 0.915

5.  Evaluation of prostate segmentation algorithms for MRI: the PROMISE12 challenge.

Authors:  Geert Litjens; Robert Toth; Wendy van de Ven; Caroline Hoeks; Sjoerd Kerkstra; Bram van Ginneken; Graham Vincent; Gwenael Guillard; Neil Birbeck; Jindang Zhang; Robin Strand; Filip Malmberg; Yangming Ou; Christos Davatzikos; Matthias Kirschner; Florian Jung; Jing Yuan; Wu Qiu; Qinquan Gao; Philip Eddie Edwards; Bianca Maan; Ferdinand van der Heijden; Soumya Ghose; Jhimli Mitra; Jason Dowling; Dean Barratt; Henkjan Huisman; Anant Madabhushi
Journal:  Med Image Anal       Date:  2013-12-25       Impact factor: 8.545

6.  Regional morphology and pathology of the prostate.

Authors:  J E McNeal
Journal:  Am J Clin Pathol       Date:  1968-03       Impact factor: 2.493

7.  [French ccAFU guidelines - update 2020-2022: prostate cancer].

Authors:  F Rozet; P Mongiat-Artus; C Hennequin; J B Beauval; P Beuzeboc; L Cormier; G Fromont-Hankard; R Mathieu; G Ploussard; R Renard-Penna; I Brenot-Rossi; F Bruyere; A Cochet; G Crehange; O Cussenot; T Lebret; X Rebillard; M Soulié; L Brureau; A Méjean
Journal:  Prog Urol       Date:  2020-11       Impact factor: 0.915

8.  PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2.

Authors:  Jeffrey C Weinreb; Jelle O Barentsz; Peter L Choyke; Francois Cornud; Masoom A Haider; Katarzyna J Macura; Daniel Margolis; Mitchell D Schnall; Faina Shtern; Clare M Tempany; Harriet C Thoeny; Sadna Verma
Journal:  Eur Urol       Date:  2015-10-01       Impact factor: 20.096

9.  EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.

Authors:  Nicolas Mottet; Joaquim Bellmunt; Michel Bolla; Erik Briers; Marcus G Cumberbatch; Maria De Santis; Nicola Fossati; Tobias Gross; Ann M Henry; Steven Joniau; Thomas B Lam; Malcolm D Mason; Vsevolod B Matveev; Paul C Moldovan; Roderick C N van den Bergh; Thomas Van den Broeck; Henk G van der Poel; Theo H van der Kwast; Olivier Rouvière; Ivo G Schoots; Thomas Wiegel; Philip Cornford
Journal:  Eur Urol       Date:  2016-08-25       Impact factor: 20.096

Review 10.  Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2.

Authors:  Baris Turkbey; Andrew B Rosenkrantz; Masoom A Haider; Anwar R Padhani; Geert Villeirs; Katarzyna J Macura; Clare M Tempany; Peter L Choyke; Francois Cornud; Daniel J Margolis; Harriet C Thoeny; Sadhna Verma; Jelle Barentsz; Jeffrey C Weinreb
Journal:  Eur Urol       Date:  2019-03-18       Impact factor: 20.096

View more
  5 in total

1.  Standardised lesion segmentation for imaging biomarker quantitation: a consensus recommendation from ESR and EORTC.

Authors:  Nandita M deSouza; Aad van der Lugt; Christophe M Deroose; Angel Alberich-Bayarri; Luc Bidaut; Laure Fournier; Lena Costaridou; Daniela E Oprea-Lager; Elmar Kotter; Marion Smits; Marius E Mayerhoefer; Ronald Boellaard; Anna Caroli; Lioe-Fee de Geus-Oei; Wolfgang G Kunz; Edwin H Oei; Frederic Lecouvet; Manuela Franca; Christian Loewe; Egesta Lopci; Caroline Caramella; Anders Persson; Xavier Golay; Marc Dewey; James P B O'Connor; Pim deGraaf; Sergios Gatidis; Gudrun Zahlmann
Journal:  Insights Imaging       Date:  2022-10-04

2.  Automatic zonal segmentation of the prostate from 2D and 3D T2-weighted MRI and evaluation for clinical use.

Authors:  Dimitri Hamzaoui; Sarah Montagne; Raphaële Renard-Penna; Nicholas Ayache; Hervé Delingette
Journal:  J Med Imaging (Bellingham)       Date:  2022-03-14

Review 3.  Comparative performance of fully-automated and semi-automated artificial intelligence methods for the detection of clinically significant prostate cancer on MRI: a systematic review.

Authors:  Michael Roberts; Leonardo Rundo; Nikita Sushentsev; Nadia Moreira Da Silva; Michael Yeung; Tristan Barrett; Evis Sala
Journal:  Insights Imaging       Date:  2022-03-28

4.  Comparative Multicentric Evaluation of Inter-Observer Variability in Manual and Automatic Segmentation of Neuroblastic Tumors in Magnetic Resonance Images.

Authors:  Diana Veiga-Canuto; Leonor Cerdà-Alberich; Cinta Sangüesa Nebot; Blanca Martínez de Las Heras; Ulrike Pötschger; Michela Gabelloni; José Miguel Carot Sierra; Sabine Taschner-Mandl; Vanessa Düster; Adela Cañete; Ruth Ladenstein; Emanuele Neri; Luis Martí-Bonmatí
Journal:  Cancers (Basel)       Date:  2022-07-27       Impact factor: 6.575

Review 5.  Artificial intelligence for prostate MRI: open datasets, available applications, and grand challenges.

Authors:  Mohammed R S Sunoqrot; Anindo Saha; Matin Hosseinzadeh; Mattijs Elschot; Henkjan Huisman
Journal:  Eur Radiol Exp       Date:  2022-08-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.